Yahoo
OTC Markets OTCQB - Delayed Quote USD

MariMed Inc. (MRMD)

0.0820 -0.0020 (-2.38%)
At close: May 14 at 4:00:00 PM EDT
MRMD Q1 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for MRMD
  • Previous Close 0.0840
  • Open 0.0800
  • Bid 0.0800 x 2000000
  • Ask 0.0830 x 3327500
  • Day's Range 0.0778 - 0.0839
  • 52 Week Range 0.0640 - 0.2300
  • Volume 144,169
  • Avg. Volume 646,158
  • Market Cap (intraday) 32.711M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date (est.) Aug 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.25

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under InHouse brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is headquartered in Norwood, Massachusetts.

www.marimedinc.com

808

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview: MRMD

Trailing total returns as of 5/14/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MRMD
12.77%
S&P 500 (^GSPC)
9.58%

1-Year Return

MRMD
2.38%
S&P 500 (^GSPC)
27.30%

3-Year Return

MRMD
83.27%
S&P 500 (^GSPC)
81.89%

5-Year Return

MRMD
90.05%
S&P 500 (^GSPC)
79.72%

Earnings Trends: MRMD

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 39.48M
Earnings --

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
10M
20M
30M
40M

Analyst Insights: MRMD

View More

Analyst Price Targets

0.25
0.25 Average
0.0820 Current
0.25 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/6/2023
Analyst Zuanic & Associates
Rating Action Initiated
Rating Overweight
Price Action --
Price Target --

Statistics: MRMD

View More

Valuation Measures

Annual
As of 5/8/2026
  • Market Cap

    33.91M

  • Enterprise Value

    110.39M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    0.65

  • Enterprise Value/Revenue

    0.69

  • Enterprise Value/EBITDA

    13.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.91%

  • Return on Assets (ttm)

    -0.40%

  • Return on Equity (ttm)

    -20.01%

  • Revenue (ttm)

    161.4M

  • Net Income Avi to Common (ttm)

    -12.76M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.94M

  • Total Debt/Equity (mrq)

    170.66%

  • Levered Free Cash Flow (ttm)

    15.24M

Compare To: MRMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: